Related Experiment Video
Updated: Jun 1, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
FOLR1 Regulates the Malignant Progression of Glioblastoma through the SRC/ERK1/2 Axis
Xueshan Jia1, Weihang Liang2, Junya Yang3
1School of Public Health, Zhengzhou University, No. 100, Science Avenue, High-tech Zone, Zhengzhou, Henan 450001, China.
Background:
GBM is an aggressive brain tumor with limited treatment options. Prior research has indicated FOLR1 as a pivotal gene involved in cancer pathogenesis.
Aim:
This study aimed to explore the involvement of folate receptor alpha (FOLR1) in glioblastoma (GBM) and evaluate its potential as a therapeutic target.
Objective:
This study investigated the expression pattern of FOLR1 in GBM, its impact on patient prognosis, and its role in GBM cell growth and the SRC/ERK1/2 signaling axis.
Methods:
Initially, we conducted an expression analysis of FOLR1 based on public databases and examined its expression pattern in GBM and its impact on patient prognosis. Subsequently, cell experiments were carried out to evaluate the regulation of GBM cells by differential FOLR1 expression. We then downloaded 100 FOLR1 co-expressed genes from the Linkedomics data repository and performed an enrichment analysis. Finally, the role of FOLR1 and SRC/ERK1/2 axis in GBM was analyzed again by cell experiments.
Results:
FOLR1 was found to be substantially expressed in GBM patients and was linked to a poor prognosis. Cell experiments showed that overexpression of FOLR1 promoted GBM cell growth, while low expression of FOLR1 inhibited cell growth. Additionally, genes related to FOLR1 were enriched in the lysosome, toxoplasmosis, and other pathways. This study further indicated that FOLR1 facilitates the activation of the SRC/ERK1/2 signaling pathway in GBM cells, and the attenuation of these pathways can effectively impede the malignancy-promoting effects triggered by FOLR1 in GBM cells.
Conclusions:
We revealed that FOLR1 orchestrates the malignant advancement of GBM by stimulating the SRC/ERK1/2 signaling axis, underscoring its pivotal role in the pathogenesis of GBM.
Insights
Folate receptor alpha (FOLR1) promotes glioblastoma (GBM) growth by activating the SRC/ERK1/2 pathway. Targeting FOLR1 may offer a new therapeutic strategy for this aggressive brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with limited therapeutic options.
- Folate receptor alpha (FOLR1) has been implicated in cancer development.
- Understanding FOLR1's role in GBM is crucial for developing new treatments.
Purpose of the Study:
- To investigate the expression and prognostic significance of FOLR1 in GBM.
- To explore the role of FOLR1 in GBM cell growth and proliferation.
- To elucidate the involvement of the SRC/ERK1/2 signaling pathway in FOLR1-mediated GBM progression.
Main Methods:
- Analysis of FOLR1 expression in public databases and GBM patient samples.
- In vitro cell experiments to assess the impact of FOLR1 expression on GBM cell growth.
- Gene co-expression network analysis and pathway enrichment analysis.
- Investigation of the SRC/ERK1/2 signaling axis in relation to FOLR1 in GBM cells.
Main Results:
- FOLR1 is highly expressed in GBM and associated with poor patient prognosis.
- Overexpression of FOLR1 enhances GBM cell growth; reduced expression inhibits it.
- FOLR1 activates the SRC/ERK1/2 signaling pathway in GBM.
- Pathway enrichment analysis revealed involvement in lysosome and toxoplasmosis pathways.
Conclusions:
- FOLR1 plays a critical role in GBM pathogenesis by promoting cell growth and activating the SRC/ERK1/2 signaling axis.
- Targeting FOLR1 and the SRC/ERK1/2 pathway presents a potential therapeutic strategy for GBM.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...